{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,11]],"date-time":"2025-04-11T22:26:10Z","timestamp":1744410370828},"reference-count":14,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2023,1,12]],"date-time":"2023-01-12T00:00:00Z","timestamp":1673481600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"name":"H.H. Lee Research Program via L.B. Research and Education Foundation to JTS"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,2,14]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>In the original clinical trials evaluating intralesional collagenase Clostridium histolyticum for Peyronie disease (PD), treatment protocols were limited to 8 injections.<\/jats:p><\/jats:sec><jats:sec><jats:title>Aim<\/jats:title><jats:p>We sought to describe our single-center experience with the use of multiple rounds (&amp;gt;8 injections) of intralesional collagenase in patients with PD.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We conducted a retrospective analysis of all patients with PD receiving intralesional collagenase injections at our institution from October 2015 through December 2020. Some patients who completed 1 round of treatment elected to undergo additional rounds (16 or 24 injections) based on persistent curvature and presence of penile plaque. Clinical improvement was defined as a 20% reduction in penile curvature from the start of a given round of treatment to the end of that round of treatment. We measured erect penile curvature before and after each round and collected demographics, medical and surgical history, curvature outcomes, and treatment-related adverse events.<\/jats:p><\/jats:sec><jats:sec><jats:title>Outcome<\/jats:title><jats:p>The primary outcome was the reduction in penile curvature after multiple rounds of treatment with intralesional collagenase injections in patients with PD.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>A total of 330 patients underwent intralesional collagenase injections for PD, of whom 229 completed at least 8 injections and underwent pre- and posttreatment erect penile goniometry. An overall 42.8% (98\/229), 38.6% (22\/57), and 12.5% (1\/8) of patients achieved clinical improvement after 1 round of therapy (8 injections), 2 rounds (16 injections), and 3 rounds (24 injections), respectively. Mean degree and mean percentage improvement of penile curvature for the start and end of each round of treatment were 8.3\u00b0 and 16.4% (after 1 round), 7.2\u00b0 and 16.8% (after 2 rounds), and 3.3\u00b0 and 8.1% (after 3 rounds). Bruising was the most common complication, with an incidence of at least 50% in each round.<\/jats:p><\/jats:sec><jats:sec><jats:title>Clinical Implications<\/jats:title><jats:p>Knowledge of patient responses to multiple rounds of intralesional collagenase injections may help guide physicians in management and counseling of patients regarding PD treatment options.<\/jats:p><\/jats:sec><jats:sec><jats:title>Strengths and Limitations<\/jats:title><jats:p>This is the first study to evaluate multiple rounds (&amp;gt;8 injections) of intralesional collagenase for PD. Limitations include retrospective analysis and smaller sample size among patients undergoing 3 rounds (24 injections).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>For patients who did not achieve clinical improvement after 1 round of treatment, an additional round may be beneficial. However, no real improvement was observed for patients undergoing a third round.<\/jats:p><\/jats:sec>","DOI":"10.1093\/jsxmed\/qdac030","type":"journal-article","created":{"date-parts":[[2023,1,12]],"date-time":"2023-01-12T10:21:28Z","timestamp":1673518888000},"page":"200-204","source":"Crossref","is-referenced-by-count":7,"title":["Multiple courses of intralesional collagenase injections for Peyronie disease: a retrospective analysis"],"prefix":"10.1093","volume":"20","author":[{"given":"Michelle K","family":"Li","sequence":"first","affiliation":[{"name":"Division of Andrology, Department of Urology, David Geffen School of Medicine at UCLA , Los Angeles, CA 90024, United States"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John T","family":"Sigalos","sequence":"additional","affiliation":[{"name":"Division of Andrology, Department of Urology, David Geffen School of Medicine at UCLA , Los Angeles, CA 90024, United States"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dar A","family":"Yoffe","sequence":"additional","affiliation":[{"name":"Division of Andrology, Department of Urology, David Geffen School of Medicine at UCLA , Los Angeles, CA 90024, United States"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neilufar","family":"Modiri","sequence":"additional","affiliation":[{"name":"Division of Andrology, Department of Urology, David Geffen School of Medicine at UCLA , Los Angeles, CA 90024, United States"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming-Yeah","family":"Hu","sequence":"additional","affiliation":[{"name":"Division of Andrology, Department of Urology, David Geffen School of Medicine at UCLA , Los Angeles, CA 90024, United States"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas W","family":"Gaither","sequence":"additional","affiliation":[{"name":"Division of Andrology, Department of Urology, David Geffen School of Medicine at UCLA , Los Angeles, CA 90024, United States"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alvaro","family":"Santamaria","sequence":"additional","affiliation":[{"name":"Division of Andrology, Department of Urology, David Geffen School of Medicine at UCLA , Los Angeles, CA 90024, United States"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dyvon T","family":"Walker","sequence":"additional","affiliation":[{"name":"School of Medicine, University of Colorado, Aurora , CO 80045, United States"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keith V","family":"Regets","sequence":"additional","affiliation":[{"name":"Division of Andrology, Department of Urology, David Geffen School of Medicine at UCLA , Los Angeles, CA 90024, United States"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jesse N","family":"Mills","sequence":"additional","affiliation":[{"name":"Division of Andrology, Department of Urology, David Geffen School of Medicine at UCLA , Los Angeles, CA 90024, United States"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sriram V","family":"Eleswarapu","sequence":"additional","affiliation":[{"name":"Division of Andrology, Department of Urology, David Geffen School of Medicine at UCLA , Los Angeles, CA 90024, United States"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2023,1,12]]},"reference":[{"key":"2023021714003797400_","doi-asserted-by":"crossref","DOI":"10.1155\/2011\/282503","article-title":"A population-based study of Peyronie\u2019s disease: prevalence and treatment patterns in the United States","volume":"2011","author":"Dibenedetti","year":"2011","journal-title":"Adv Urol."},{"key":"2023021714003797400_","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/sj.ijir.3900863","article-title":"Epidemiology of Peyronie\u2019s disease","volume":"14","author":"Sommer","year":"2002","journal-title":"Int J Impot Res."},{"key":"2023021714003797400_","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1111\/j.1743-6109.2012.02999.x","article-title":"Psychological impact of Peyronie\u2019s disease: a review","volume":"10","author":"Nelson","year":"2013","journal-title":"J Sex Med."},{"key":"2023021714003797400_","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.juro.2015.05.098","article-title":"Peyronie\u2019s disease: AUA guideline","volume":"194","author":"Nehra","year":"2015","journal-title":"J Urol."},{"key":"2023021714003797400_","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.juro.2013.01.087","article-title":"Clinical efficacy, safety and tolerability of collagenase Clostridium histolyticum for the treatment of Peyronie disease in 2 large double-blind, randomized, placebo controlled phase 3 studies","volume":"190","author":"Gelbard","year":"2013","journal-title":"J Urol."},{"key":"2023021714003797400_","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/s00345-019-02817-4","article-title":"Managing complications of collagenase Clostridium histolyticum (CCH) injection","volume":"38","author":"Greear","year":"2020","journal-title":"World J Urol."},{"key":"2023021714003797400_","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1177\/1756287218755020","article-title":"Intralesional collagenase Clostridium histolyticum in the management of Peyronie\u2019s disease: current best practice","volume":"10","author":"Cwikla","year":"2018","journal-title":"Ther Adv Urol."},{"key":"2023021714003797400_","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.urology.2016.09.050","article-title":"Impact of number of cycles of collagenase Clostridium histolyticum on outcomes in patients with Peyronie\u2019s disease","volume":"100","author":"Anaissie","year":"2017","journal-title":"Urology."},{"key":"2023021714003797400_","doi-asserted-by":"crossref","first-page":"894","DOI":"10.21037\/tau.2017.07.27","article-title":"Effect of collagenase Clostridium histolyticum on penile vascular and morphological parameters in patients with Peyronie\u2019s disease","volume":"6","author":"Diao","year":"2017","journal-title":"Transl Androl Urol."},{"key":"2023021714003797400_","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/s00345-019-02812-9","article-title":"A modified technique for intralesional injection of collagenase Clostridium histolyticum for Peyronie\u2019s disease results in reduced procedural morbidity using a standardized hematoma classification rubric","volume":"38","author":"Amighi","year":"2020","journal-title":"World J Urol."},{"key":"2023021714003797400_","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1097\/JU.0000000000002789","article-title":"Acute lower back pain after intralesional injection of collagenase Clostridium histolyticum for Peyronie\u2019s disease","volume":"208","author":"Sigalos","year":"2022","journal-title":"J Urol."},{"key":"2023021714003797400_","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s40261-019-00867-5","article-title":"Collagenase Clostridium histolyticum: a review in Peyronie\u2019s disease","volume":"40","author":"Hoy","year":"2020","journal-title":"Clin Drug Investig."},{"key":"2023021714003797400_","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.jsxm.2019.11.271","article-title":"Peyronie\u2019s disease intervention studies: an exploration of modern-era challenges in study design and evaluating treatment outcomes","volume":"17","author":"Ziegelmann","year":"2020","journal-title":"J Sex Med."},{"key":"2023021714003797400_","doi-asserted-by":"crossref","DOI":"10.1038\/s41443-021-00486-9","article-title":"3D-printed phantoms to quantify accuracy and variability of goniometric and volumetric assessment of Peyronie\u2019s disease deformities","author":"Walker","year":"2022;34(8):786-789","journal-title":"Int J Impot Res."}],"container-title":["The Journal of Sexual Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jsm\/article-pdf\/20\/2\/200\/49232816\/qdac030.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jsm\/article-pdf\/20\/2\/200\/49232816\/qdac030.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,20]],"date-time":"2023-03-20T20:14:53Z","timestamp":1679343293000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jsm\/article\/20\/2\/200\/6986019"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,12]]},"references-count":14,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2023,1,12]]},"published-print":{"date-parts":[[2023,2,14]]}},"URL":"https:\/\/doi.org\/10.1093\/jsxmed\/qdac030","relation":{},"ISSN":["1743-6095","1743-6109"],"issn-type":[{"value":"1743-6095","type":"print"},{"value":"1743-6109","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,2]]},"published":{"date-parts":[[2023,1,12]]}}}